Dr. Amy D. Tiersten
Claim this profileIcahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology
Area of expertise
Breast Cancer
Amy D. Tiersten has run 9 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Amy D. Tiersten has run 3 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Icahn School Of Medicine At Mount Sinai Division Of Hematology And Medical Oncology
Icahn School Of Medicine At Mount Sinai
Clinical Trials Amy D. Tiersten is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting
2 awards
Phase 3
12 criteria
Sacituzumab + Cisplatin
for Ovarian and Uterine Cancer
This is an open-label, Phase 1 study with a dose expansion cohort of Sacituzumab Govitecan in Combination with Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. The goal of the study is to determine the optimal dose of sacituzumab govitecan for use in combination with cisplatin for treatment of epithelial ovarian and endometrial cancers.
Recruiting
1 award
Phase 1 & 2
9 criteria
More about Amy D. Tiersten
Clinical Trial Related
2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Amy D. Tiersten has experience with
- Abemaciclib
- Palbociclib
- Pertuzumab
- Trastuzumab
- Carboplatin
- Everolimus
Breakdown of trials Amy D. Tiersten has run
Breast Cancer
Breast cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy D. Tiersten specialize in?
Amy D. Tiersten focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Amy D. Tiersten currently recruiting for clinical trials?
Yes, Amy D. Tiersten is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Amy D. Tiersten has studied deeply?
Yes, Amy D. Tiersten has studied treatments such as Abemaciclib, Palbociclib, Pertuzumab.
What is the best way to schedule an appointment with Amy D. Tiersten?
Apply for one of the trials that Amy D. Tiersten is conducting.
What is the office address of Amy D. Tiersten?
The office of Amy D. Tiersten is located at: Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.